{"id":160828,"date":"2022-10-21T10:35:19","date_gmt":"2022-10-21T06:35:19","guid":{"rendered":""},"modified":"-0001-11-30T00:00:00","modified_gmt":"-0001-11-29T20:00:00","slug":"","status":"publish","type":"post","link":"https:\/\/ucnoqta.az\/?p=160828","title":{"rendered":"<font color=red><b>Nikahdan \u00f6nc\u0259 tibbi m\u00fcayin\u0259<\/b><\/font> &#8211; Valideynl\u0259r \u00f6vladlar\u0131n\u0131n qatilin\u0259 \u00e7evrilm\u0259m\u0259lidir"},"content":{"rendered":"<p><strong>Az\u0259rbaycan talassemiyan\u0131n geni\u015f yay\u0131ld\u0131\u011f\u0131 &ouml;lk\u0259l\u0259r s\u0131ras\u0131ndad\u0131r. Talassemiyal\u0131 insanlar\u0131n normalda oldu\u011fundan daha az hemoqlobini v\u0259 &ccedil;ox az q\u0131rm\u0131z\u0131 qan h&uuml;ceyr\u0259si olur. Bu x\u0259st\u0259liyin yay\u0131lmas\u0131n\u0131n qar\u015f\u0131s\u0131n\u0131 almaq &uuml;&ccedil;&uuml;n yollardan biri nikaha girm\u0259zd\u0259n \u0259vv\u0259l c&uuml;tl&uuml;kl\u0259rin tibbi m&uuml;ayin\u0259d\u0259n ke&ccedil;m\u0259yidir. \u018fg\u0259r iki talassemiya da\u015f\u0131y\u0131c\u0131s\u0131 evl\u0259nirs\u0259, onlar\u0131n u\u015fa\u011f\u0131n\u0131n talassemiyal\u0131 olma ehtimal\u0131 25 faizdir. \u018fg\u0259r iki talassemiya x\u0259st\u0259si evl\u0259nirs\u0259, onlar\u0131n &ouml;vlad\u0131 bu x\u0259st\u0259liyi irs\u0259n alacaq.<\/strong><\/p>\n<p>Bu v\u0259 dig\u0259r m\u0259s\u0259l\u0259l\u0259rl\u0259 ba\u011fl\u0131 Ucnoqta.az-\u0131n suallar\u0131n\u0131 M\u0259rk\u0259zi Qan Bank\u0131n\u0131n L\u0259nk\u0259ran b&ouml;lm\u0259sinin m&uuml;diri \u0130lkin \u018fs\u0259dullayev cavabland\u0131r\u0131r.<br \/>\n<img decoding=\"async\" alt=\"\" src=\"http:\/\/ucnoqta.az\/cdn\/2022\/october\/21\/medium\/IMG8685.jpg\" style=\"width: 400px; height: 250px;\" \/><br \/>\n<strong>&ndash; Talassemiya x\u0259st\u0259liyinin yay\u0131lmas\u0131n\u0131n qar\u015f\u0131s\u0131n\u0131 almaq &uuml;&ccedil;&uuml;n yollardan biri nikaha girm\u0259zd\u0259n \u0259vv\u0259l c&uuml;tl&uuml;kl\u0259rin tibbi m&uuml;ayin\u0259d\u0259n ke&ccedil;m\u0259sidir. L\u0259nkaranda bu i\u015f nec\u0259 t\u0259\u015fkil olunur?<\/strong><br \/>\n&ndash;&nbsp; 2015-ci il\u0259d\u0259k evl\u0259nm\u0259k ist\u0259y\u0259n c&uuml;tl&uuml;kl\u0259r tibbi m&uuml;ayin\u0259d\u0259n ke&ccedil;mirdil\u0259r v\u0259 talassemiyal\u0131 olduqlar\u0131na dair m\u0259lumatl\u0131 deyildil\u0259r v\u0259 d&uuml;nyaya x\u0259st\u0259 u\u015faqlar g\u0259tirilm\u0259si riski art\u0131rd\u0131. V\u0259ziyy\u0259t 2015-ci ild\u0259n d\u0259yi\u015fm\u0259y\u0259 ba\u015flad\u0131. H\u0259min ild\u0259n b\u0259ri Az\u0259rbaycanda evl\u0259nm\u0259y\u0259 haz\u0131rla\u015fan c&uuml;tl&uuml;kl\u0259r tibbi m&uuml;ayin\u0259d\u0259n ke&ccedil;irl\u0259r. L\u0259nkaranda b&uuml;t&uuml;n c&uuml;tl&uuml;kl\u0259rin talassemiya da\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131na g&ouml;r\u0259 yoxlan\u0131lmas\u0131n\u0131 biz h\u0259yata ke&ccedil;iririk. Y\u0259ni L\u0259nk\u0259ran Qan M\u0259rk\u0259zind\u0259. B&uuml;t&uuml;n c&uuml;tl&uuml;kl\u0259r h&ouml;km\u0259n m&uuml;ayin\u0259d\u0259n ke&ccedil;irl\u0259r. Ola bilsin ki b\u0259zi c&uuml;tl&uuml;kl\u0259r\u0259 m&uuml;ayin\u0259nin n\u0259tic\u0259l\u0259ri a&ccedil;\u0131qlanmadan \u0259vv\u0259l aray\u0131\u015f verilsin. Bunun &uuml;&ccedil;&uuml;n ciddi s\u0259b\u0259bl\u0259r olmal\u0131d\u0131r.<\/p>\n<p>Tibbi m&uuml;ayin\u0259d\u0259n sonra c&uuml;tl&uuml;kl\u0259r tibbi aray\u0131\u015f al\u0131rlar. Bu aray\u0131\u015fda m&uuml;ayin\u0259nin n\u0259tic\u0259l\u0259ri qeyd olunur. Tibbi m&uuml;ayin\u0259nin n\u0259tic\u0259l\u0259ri m&uuml;sb\u0259tdirs\u0259, c&uuml;tl&uuml;kl\u0259ri t\u0259brik edir, xo\u015fb\u0259xtlik arzulay\u0131r\u0131q. Amma n\u0259tic\u0259l\u0259r h\u0259mi\u015f\u0259 m&uuml;sb\u0259t olmur. Bu bar\u0259d\u0259 d\u0259 onlar\u0131 m\u0259lumatland\u0131r\u0131r\u0131q: sizd\u0259 talassemiya x\u0259st\u0259liyi var (ola bilsin birind\u0259 v\u0259 ya h\u0259r ikisind\u0259), ya onun da\u015f\u0131y\u0131c\u0131s\u0131s\u0131n\u0131z. G\u0259l\u0259c\u0259kd\u0259 ortaya &ccedil;\u0131xacaq probleml\u0259r bar\u0259d\u0259 m\u0259lumatland\u0131r\u0131r\u0131q, evl\u0259ndikd\u0259n sonra do\u011fulan u\u015faqda m&uuml;\u0259yy\u0259n f\u0259sadlar ola bil\u0259c\u0259yi bar\u0259d\u0259 x\u0259b\u0259rdarl\u0131q edirik. &Ccedil;al\u0131\u015f\u0131r\u0131q ki, evlilik q\u0259rar\u0131ndan d&ouml;n\u0259 bilsinl\u0259r. Bundan sonra se&ccedil;im onlar\u0131n olur, ail\u0259nin d\u0259, g\u0259l\u0259c\u0259k n\u0259slin sa\u011flaml\u0131\u011f\u0131 onlardan as\u0131l\u0131d\u0131r. Normal, a\u011fl\u0131 ba\u015f\u0131nda insan anlamal\u0131d\u0131r ki, ail\u0259 qurmaq yaln\u0131z iki n\u0259f\u0259rin birg\u0259 ya\u015fay\u0131\u015f\u0131ndan ibar\u0259t deyil. Ata da, ana da &ouml;vladlar\u0131n\u0131n qatilin\u0259 &ccedil;evrilm\u0259m\u0259lidirl\u0259r. Hans\u0131sa x\u0259st\u0259 c&uuml;tl&uuml;kd\u0259n sabah x\u0259st\u0259 u\u015faq d&uuml;nyaya g\u0259l\u0259c\u0259ks\u0259, bunun g&uuml;nahkar\u0131 da valideynl\u0259r olacaq. &nbsp;Bu s\u0259b\u0259bd\u0259n d\u0259 &ccedil;al\u0131\u015f\u0131r\u0131q ki, evlilik q\u0259rar\u0131ndan d&ouml;n\u0259 bilsinl\u0259r. Bundan sonra se&ccedil;im onlar\u0131n olur. H\u0259r bir insan\u0131n h&uuml;ququ var, h\u0259r k\u0259s &ouml;z q\u0259rar\u0131n\u0131 &ouml;z&uuml; verm\u0259lidir. Qeyd edim ki, nikahdan \u0259vv\u0259l tibbi m&uuml;ayin\u0259 talassemiya il\u0259 do\u011fulan u\u015faqlar\u0131n say\u0131n\u0131 \u0259h\u0259miyy\u0259tli d\u0259r\u0259c\u0259d\u0259 azalmas\u0131na s\u0259b\u0259b olub.<\/p>\n<p><strong>&#8211; Qank&ouml;&ccedil;&uuml;rm\u0259 insan\u0131n h\u0259yat\u0131n\u0131 xilas edir.&nbsp;Hans\u0131 qan qrupu hans\u0131na k&ouml;&ccedil;&uuml;r&uuml;l\u0259 bil\u0259r?<\/strong><br \/>\n&ndash; Talassemiya x\u0259st\u0259l\u0259rinin m&uuml;alic\u0259sind\u0259 qan &ouml;n\u0259mli rol oynay\u0131r. Lakin x\u0259st\u0259y\u0259 ist\u0259nil\u0259n qrupdan qan k&ouml;&ccedil;&uuml;rm\u0259k olmaz. Qank&ouml;&ccedil;&uuml;rm\u0259 zaman\u0131 t\u0259k qan qrupu deyil, rezus faktor (m&uuml;sb\u0259t v\u0259 ya m\u0259nfi ola bil\u0259r) n\u0259z\u0259r\u0259 al\u0131nmal\u0131d\u0131r. D&uuml;nyada insanlar\u0131n 85 faizi m&uuml;sb\u0259t qan rezusuna malik oldu\u011fu halda, 15 faizinin qan\u0131 m\u0259nfi rezus olur. H\u0259mi\u015f\u0259 e\u015fitmisiniz ki, I Qan qrupu b&uuml;t&uuml;n qan qruplar\u0131na qan ver\u0259 bil\u0259r. \u0130ndi d\u0259 ver\u0259 bil\u0259r. D&uuml;nyada n\u0259 q\u0259d\u0259r insan varsa, o q\u0259d\u0259r d\u0259 qan qrupu var. Biz \u015f\u0259rti olaraq qan qruplar\u0131n\u0131 8 qrupa b&ouml;l&uuml;r&uuml;k. Bu qruplar\u0131n da alt qruplar\u0131 var. Talassemiya x\u0259st\u0259sin\u0259 qan k&ouml;&ccedil;&uuml;r&uuml;l\u0259rk\u0259n bunlar n\u0259z\u0259r\u0259 al\u0131n\u0131r. &Ccedil;&uuml;nki uy\u011fun olmayan qan\u0131n k&ouml;&ccedil;&uuml;r&uuml;lm\u0259si n\u0259tic\u0259sind\u0259 orqanizmin b&uuml;t&uuml;n sisteml\u0259rind\u0259 a\u011f\u0131r pozuntular yaran\u0131r.<\/p>\n<p>Haz\u0131rda L\u0259nk\u0259ran b&ouml;lg\u0259sind\u0259 300-400 talassemiya x\u0259st\u0259si var ki, onlardan da 40 n\u0259f\u0259r\u0259 yax\u0131n\u0131 aktiv transfuziya al\u0131r. Onlar\u0131n qan\u0131nda par&ccedil;alanma olur v\u0259 aktiv \u015f\u0259kild\u0259 qan (eritrosid k&uuml;tl\u0259) k&ouml;&ccedil;&uuml;r&uuml;l&uuml;r. Yuxar\u0131da qeyd etdiyim kimi, x\u0259st\u0259y\u0259 qan k&ouml;&ccedil;&uuml;r&uuml;l\u0259rk\u0259n diqq\u0259tli olmaq laz\u0131md\u0131r. H&ouml;km\u0259n x\u0259st\u0259 &uuml;&ccedil;&uuml;n uy\u011fun qan qrupu se&ccedil;ilm\u0259lidir. Se&ccedil;im is\u0259 m&uuml;asir &uuml;sullarla h\u0259yata ke&ccedil;irilir. M\u0259s\u0259l\u0259n, biz\u0259 I qrup talassemiya x\u0259st\u0259si m&uuml;raci\u0259t ed\u0259nd\u0259, ilk n&ouml;vb\u0259d\u0259 onun qan\u0131ndan n&uuml;mun\u0259 g&ouml;t&uuml;r&uuml;r&uuml;k, bu n&uuml;mun\u0259 \u0259sas\u0131nda da qan\u0131n hans\u0131 alt qrupuna aid oldu\u011funu t\u0259yin edirik v\u0259 uy\u011fun qan\u0131 se&ccedil;irik. V\u0259 ya x\u0259st\u0259nin qan\u0131ndan n&uuml;mun\u0259 g&ouml;t&uuml;r&uuml;r&uuml;k, bizd\u0259 m&ouml;vcud olan 8 qandan da n&uuml;mun\u0259 g&ouml;t&uuml;r&uuml;b yoxlay\u0131r\u0131q. N\u0259tic\u0259d\u0259 x\u0259st\u0259y\u0259 daha uy\u011fun qan\u0131, daha a\u011f\u0131rla\u015fma verm\u0259y\u0259n qan\u0131 g&ouml;t&uuml;r&uuml;r&uuml;k. Bel\u0259 olan halda transfusiya m&uuml;dd\u0259ti, y\u0259ni iki qank&ouml;&ccedil;&uuml;rm\u0259 aras\u0131nda m&uuml;dd\u0259t uzan\u0131r. N\u0259tic\u0259d\u0259 art\u0131q miqdarda d\u0259mirin toplanmas\u0131 da azal\u0131r. Xat\u0131rlad\u0131m ki, talassemiya x\u0259st\u0259l\u0259rinin \u0259n b&ouml;y&uuml;k problemi m&uuml;t\u0259madi qan transfuziyas\u0131 (qan k&ouml;&ccedil;&uuml;r&uuml;lm\u0259si) il\u0259 \u0259laq\u0259dar orqanizml\u0259rd\u0259 par&ccedil;alanma m\u0259hsulu olan d\u0259mirin toplanmas\u0131d\u0131r. N\u0259tic\u0259d\u0259, d\u0259mir m&uuml;xt\u0259lif toxumalarda &#8211; &uuml;r\u0259k v\u0259 qaraciy\u0259rd\u0259 toplanaraq f\u0259sadlar t&ouml;r\u0259dir. Bel\u0259 x\u0259st\u0259l\u0259rin m&uuml;alic\u0259si zaman\u0131 xelator (d\u0259mirt\u0259mizl\u0259m\u0259) preparatlar\u0131ndan istifad\u0259 olunur.<\/p>\n<p><strong>&#8211; Qan donorlar\u0131 kiml\u0259r ola bil\u0259r?<\/strong><br \/>\n-Ya\u015f h\u0259ddi 18-65 aras\u0131nda, &ccedil;\u0259kisi is\u0259 50 kq-dan yuxar\u0131 olan \u015f\u0259xsl\u0259r donor ola bil\u0259r. Bunun &uuml;&ccedil;&uuml;n \u015f\u0259xsiyy\u0259t v\u0259siq\u0259si il\u0259 m&uuml;raci\u0259t etm\u0259k laz\u0131md\u0131r. Donor qan verm\u0259d\u0259n \u0259vv\u0259l \u0259n az\u0131 son iki saat \u0259rzind\u0259 m&uuml;xt\u0259lif qida v\u0259 mayel\u0259r q\u0259bul etm\u0259lidir. Donor olmaq ist\u0259y\u0259n \u015f\u0259xsin \u015f\u0259xsiyy\u0259t v\u0259siq\u0259sini qeydiyyata al\u0131n\u0131r v\u0259 hemoqlobinin miqdar\u0131 yoxlan\u0131l\u0131r. Hemoqlobinin miqdar\u0131&nbsp; normal olduqdan (Qan donoru olmaq &uuml;&ccedil;&uuml;n hemoqlobin s\u0259viyy\u0259si ki\u015fil\u0259rd\u0259 minimum 13,5g\/dl, maksimum 18,0 g\/dl, qad\u0131nlarda is\u0259 12,5 g\/dl, maksimum 16,5 g\/dl olmal\u0131d\u0131r.Hemoqlobinin miqdar\u0131 qad\u0131nlarda 120 q\/l-d\u0259n, ki\u015fil\u0259rd\u0259 is\u0259 130q\/l-d\u0259n az olmamal\u0131d\u0131r) &nbsp;sonra h\u0259kim m&uuml;ayin\u0259sind\u0259n ke&ccedil;irilirOnun n\u0259bzi, t\u0259zyiq v\u0259 temperaturu yoxlan\u0131l\u0131r, m&uuml;xt\u0259lif suallar verilir. M&uuml;ayin\u0259 zaman\u0131 donorda n\u0259bzin vurmas\u0131 m&uuml;nt\u0259z\u0259m olaraq bir d\u0259qiq\u0259d\u0259 50-100, sistolik qan t\u0259zyiqi 180 mm c.s, diastolik t\u0259zyiq is\u0259 100 mm c.s-d\u0259n art\u0131q olmamal\u0131d\u0131r. Donorun tibbi m&uuml;ayin\u0259d\u0259n ke&ccedil;m\u0259si, qan\u0131n, qan komponentl\u0259rinin g&ouml;t&uuml;r&uuml;lm\u0259si qaydas\u0131na \u0259sas\u0259n h\u0259yata ke&ccedil;irilir.&nbsp; Donorlar\u0131n\u0131n tibbi m&uuml;ayin\u0259d\u0259n ke&ccedil;irilm\u0259sind\u0259 \u0259sas m\u0259qs\u0259d onlar\u0131n sa\u011flaml\u0131\u011f\u0131n\u0131n q\u0259na\u0259tb\u0259x\u015f olmas\u0131n\u0131 t\u0259yin etm\u0259kl\u0259 yana\u015f\u0131, h\u0259m donorlar\u0131n, h\u0259m d\u0259 resipiyentl\u0259rin sa\u011flaml\u0131\u011f\u0131na x\u0259l\u0259l g\u0259tirm\u0259m\u0259kdir. Donor olmaq ist\u0259y\u0259n h\u0259r bir \u015f\u0259xs &ouml;z s\u0259hh\u0259ti, ke&ccedil;irdiyi v\u0259 haz\u0131rk\u0131 x\u0259st\u0259likl\u0259ri, h\u0259m&ccedil;inin narkotik&nbsp;vasit\u0259l\u0259r v\u0259 psixotrop&nbsp;madd\u0259l\u0259r q\u0259bul edib-etm\u0259m\u0259si v\u0259 s. bar\u0259d\u0259 aidiyy\u0259ti tibb i\u015f&ccedil;isin\u0259 d&uuml;zg&uuml;n m\u0259lumat verm\u0259li v\u0259 Az\u0259rbaycan Respublikas\u0131n\u0131n S\u0259hiyy\u0259 Nazirliyi t\u0259r\u0259find\u0259n t\u0259sdiq edil\u0259n x&uuml;susi sor\u011fu v\u0259r\u0259q\u0259sini doldurmal\u0131d\u0131r.&nbsp;Yaln\u0131z sa\u011flam v\u0259 he&ccedil; bir \u0259ks-g&ouml;st\u0259ricil\u0259ri (donorlu\u011fa m&uuml;v\u0259qq\u0259ti \u0259ksg&ouml;st\u0259ri\u015fl\u0259r \u0259lav\u0259 olunur) olmayan \u015f\u0259xsl\u0259r m&uuml;alic\u0259 m\u0259qs\u0259dil\u0259 istifad\u0259 edil\u0259n qan m\u0259hsullar\u0131n\u0131n donoru ola bil\u0259rl\u0259r.<\/p>\n<p>Qan donorlar\u0131n\u0131n qanverm\u0259 prosedurlar\u0131 aras\u0131ndak\u0131 interval, ki\u015fil\u0259r il \u0259rzind\u0259 4 d\u0259f\u0259, qad\u0131nlar is\u0259 3 d\u0259f\u0259 qan ver\u0259 bil\u0259r. Qan al\u0131nd\u0131qdan sonra h\u0259min k&uuml;tl\u0259 3 \u0259sas hiss\u0259y\u0259- eritrosit k&uuml;tl\u0259sin\u0259, trombosit v\u0259 plazmaya ayr\u0131l\u0131r. Bu elementl\u0259r is\u0259 h\u0259r biri m&uuml;xt\u0259lif x\u0259st\u0259likl\u0259rd\u0259 istifad\u0259 olunur. Bir n\u0259f\u0259r qan ver\u0259n \u015f\u0259xs &uuml;&ccedil; n\u0259f\u0259rin h\u0259yat\u0131n\u0131 xilas etmi\u015f olur.<\/p>\n<p><strong>P&uuml;nhan \u018ff\u0259ndiyev<\/strong><\/p>\n<p><em>Yaz\u0131 &quot;Leykozlu U\u015faqlara D\u0259st\u0259k&quot; ictimai birliyinin Az\u0259rbaycan Respublikas\u0131n\u0131n Qeyri-H&ouml;kum\u0259t T\u0259\u015fkilatlar\u0131na D&ouml;vl\u0259t D\u0259st\u0259yi Agentliyinin maliyy\u0259 yard\u0131m\u0131 il\u0259 &ldquo;Regionlarda talassemiya v\u0259 qan donorlu\u011fu bar\u0259d\u0259 maarifl\u0259ndirm\u0259&rdquo; layih\u0259si &ccedil;\u0259r&ccedil;iv\u0259sind\u0259 haz\u0131rlanm\u0131\u015fd\u0131r.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Az\u0259rbaycan talassemiyan\u0131n geni\u015f yay\u0131ld\u0131\u011f\u0131 &ouml;lk\u0259l\u0259r s\u0131ras\u0131ndad\u0131r. Talassemiyal\u0131 insanlar\u0131n normalda oldu\u011fundan daha az hemoqlobini v\u0259 &ccedil;ox az q\u0131rm\u0131z\u0131 qan h&uuml;ceyr\u0259si olur. Bu x\u0259st\u0259liyin yay\u0131lmas\u0131n\u0131n qar\u015f\u0131s\u0131n\u0131 almaq &uuml;&ccedil;&uuml;n yollardan biri nikaha girm\u0259zd\u0259n&hellip;<\/p>\n","protected":false},"author":1,"featured_media":251278,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[108],"tags":[],"class_list":["post-160828","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-leykoz"],"_links":{"self":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts\/160828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=160828"}],"version-history":[{"count":0,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts\/160828\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/media\/251278"}],"wp:attachment":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=160828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=160828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=160828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}